alcohol Archives

The Authors’ Own Words: Lifetime Marijuana and Alcohol Use, and Cognitive Dysfunction in People with Human Immunodeficiency Virus Infection

Dec 12, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Lifetime Marijuana and Alcohol Use, and Cognitive Dysfunction in People with Human Immunodeficiency Virus Infection

Sara A. Lorkiewicz, MS; Alicia S. Ventura, MPH; Timothy C. Heeren, PhD; Michael R. Winter, MPH; Alexander Y. Walley, MD, MSc; Meg Sullivan, MD; Jeffrey H. Samet, MD, MA, MPH; & Richard Saitz, MD, MPH

Substance Abuse Vol. 39, Iss. 1, 2018

“Alcohol and other drug use are common among people with HIV infection. HIV can be neurotoxic, alcohol is a known neurotoxin and marijuana can alter brain metabolism and affect neuronal networks. In this study, although effects of alcohol use were not detected, current marijuana use was associated with cognitive dysfunction. The association is particularly important because people with HIV infection may already be susceptible to cognitive dysfunction, and such dysfunction could interfere with their self-care and quality of life.”

The Authors’ Own Words: Interest in using mobile technology to help self-manage alcohol use among persons living with HIV: A Florida Cohort cross-sectional study

Dec 9, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Interest in using mobile technology to help self-manage alcohol use among persons living with HIV: A Florida Cohort cross-sectional study

J. Danielle Sharpe, MS; Zhi Zhou, DDS, MPH; César G. Escobar-Viera, MD, PhD; Jamie P. Morano, MD, MPH; Robert J. Lucero, PhD, MPH, RN; Gladys E. Ibañez, PhD; Mark Hart, EdD, MALS; Christa L. Cook, PhD, MSN, RN; & Robert L. Cook, MD, MPH

Substance Abuse Vol. 39, Iss. 1, 2018

“Our manuscript contributes to the literature in regards to informing the development of mobile technology-based interventions for persons living with HIV who have hazardous alcohol use issues. To the knowledge of my co-authors and I, no previous research has explored mobile technology usage and the interest of PLWH who drink to use mobile technology for alcohol-related health interventions, and our study is the first to explore this. Our study found that PLWH who drink demonstrated moderate mobile technology use and were fairly willing to use a cell phone app to manage alcohol use, indicating that a portion of PLWH who drink have the interest and technological capacity for a mobile technology-based intervention to reduce alcohol consumption. These findings will be useful to researchers who are designing mobile technology-based interventions aimed at helping PLWH self-manage their alcohol use behavior to improve their HIV health outcomes.”

The Authors’ Own Words: Single and dual diagnoses of Major Depressive Disorder and Post-Traumatic Stress Disorder predicted by triple comorbid trajectories of tobacco, alcohol, and marijuana use among urban adults

Nov 20, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Single and dual diagnoses of Major Depressive Disorder and Post-Traumatic Stress Disorder predicted by triple comorbid trajectories of tobacco, alcohol, and marijuana use among urban adults

Substance Abuse Vol. 40, Iss. 2, 2019

“As the prevalence of substance use increases, it is significant to examine the associations between earlier use of three substances simultaneously and later MDD and/or PTSD. From a clinical perspective, individuals presenting with tobacco, alcohol, and marijuana use should be evaluated for MDD and/or PTSD. The findings of the present study could lead to improvements in individualized treatments for African American and Puerto Rican patients who have both MDD and PTSD and who also use tobacco, alcohol, and marijuana.“